Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
-
Agile Therapeutics to Participate in Upcoming March Investor Events
-
Agile Therapeutics to Participate in Maxim Group’s Leading Innovators in Women’s Health Virtual Conference
-
Agile Therapeutics to Participate in Maxim Group’s Leading Innovators in Women’s Health Virtual Conference
-
Agile Therapeutics (AGRX) Prices 15M Share Offering at $3/Sh
-
Agile Therapeutics Announces Pricing of $45 Million Underwritten Public Offering of Common Stock
-
Agile Therapeutics Announces Pricing of $45 Million Underwritten Public Offering of Common Stock
-
Agile Therapeutics (AGRX) to Offer Common Stock
-
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
-
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
-
Agile Therapeutics (AGRX) Impact From FDA Clinical Guidance - Maxim
-
Maxim Group Starts Agile Therapeutics (AGRX) at Buy
